UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk factors of reattempt among suicide attempters in South Korea: A nationwide retrospective cohort study

PloS one, 2024-04, Vol.19 (4), p.e0300054-e0300054

2024

Volltextzugriff (PDF)

A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects

British journal of clinical pharmacology, 2016-07, Vol.82 (1), p.64-73

2016

Volltextzugriff (PDF)

A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade®) in Healthy Subjects

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2015-12, Vol.29 (6), p.381-388

2015

Volltextzugriff (PDF)

Efficacy and Safety of Infliximab in Intestinal Behçet's Disease: A Multicenter, Phase 3 Study (BEGIN)

Gut and Liver, 2023, 17(5), , pp.777-785

2023

Volltextzugriff (PDF)

Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study

Gut and Liver, 2022, 16(5), , pp.764-774

2022

Volltextzugriff (PDF)

Safety and Effectiveness of Darunavir in Korean Patients with Human Immunodeficiency Virus 1 Infection: A Post-Marketing Observational Study

Infection & chemotherapy, 2021-09, Vol.53 (3), p.539

2021

Volltextzugriff (PDF)

A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects

Clinical therapeutics, 2016-07, Vol.38 (7), p.1665-1673.e3

2016

Volltextzugriff (PDF)

Quality of Life in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: Changes in the MOSAIK Cohort Over 1 Year

Gut and Liver, 2022, 16(3), , pp.384-395

2022

Volltextzugriff (PDF)

Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: results from the MOSAIK cohort in Korea

BMC gastroenterology, 2023-11, Vol.23 (1), p.1-405, Article 405

2023

Volltextzugriff (PDF)

Clinical outcomes in adult patients with plaque psoriasis treated with ustekinumab under real‐world practice in Korea: A prospective, observational, multi‐center, postmarketing surveillance study

Journal of dermatology, 2021-06, Vol.48 (6), p.778-785

2021

Volltextzugriff (PDF)

Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea

Gut and liver, 2020-07, Vol.14 (4), p.459-467

2020

Volltextzugriff (PDF)

Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasis

Journal of dermatology, 2017-05, Vol.44 (5), p.560-566

2017

Volltextzugriff (PDF)

Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea

Gut and liver, 2021-01, Vol.15 (1), p.146-147

2021

Volltextzugriff (PDF)

Tu1825 EFFECTIVENESS OF EARLY THIOPURINE USE IN KOREAN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE MULTICENTER COHORT (MOSAIK) STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1424-S-1424

2024

Volltextzugriff (PDF)

Effectiveness of Early Thiopurine Use in Korean Patients With Moderate-to-Severe Ulcerative Colitis: A Prospective Multicenter Cohort (MOSAIK) Study

Journal of clinical gastroenterology, 2024-10

2024

Volltextzugriff (PDF)

Mo1855 ONE-YEAR SAFETY AND EFFECTIVENESS OF USTEKINUMAB IN PATEITNS WITH CROHN'S DISEASE: THE K-STAR STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1145-S-1145

2024

Volltextzugriff (PDF)

One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn's Disease: The K-STAR Study

Inflammatory bowel diseases, 2024-08

2024

Volltextzugriff (PDF)

Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea

Rheumatology and therapy., 2021-09, Vol.8 (3), p.1393-1404

2021

Volltextzugriff (PDF)

EP1027: DISCORDANCE BETWEEN PATIENT-REPORTED SYMPTOMS AND ENDOSCOPIC MUCOSAL INFLAMMATION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1035-S-1036

2022

Volltextzugriff (PDF)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Gut and liver, 2023-09, Vol.17 (5), p.777

2023

Volltextzugriff (PDF)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Gut and liver, 2023-09, Vol.17 (5), p.777

2023

Volltextzugriff (PDF)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Gut and liver, 2023-09, Vol.17 (5), p.777

2023

Volltextzugriff (PDF)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Gut and liver, 2023-09, Vol.17 (5), p.777

2023

Volltextzugriff (PDF)

Early course of newly diagnosed moderate‐to‐severe ulcerative colitis in Korea: Results from a hospital‐based inception cohort study (MOSAIK)

Journal of gastroenterology and hepatology, 2021-08, Vol.36 (8), p.2149-2156

2021

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(53)

Sprache

Englisch
(30)
Koreanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Risk factors of reattempt among suicide attempters in South Korea: A nationwide retrospective cohort study

A randomized phase l pharmacokinetic study comparing SB4 and etanercept reference product (Enbrel®) in healthy subjects

A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade®) in Healthy Subjects

Efficacy and Safety of Infliximab in Intestinal Behçet's Disease: A Multicenter, Phase 3 Study (BEGIN)

Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study

Safety and Effectiveness of Darunavir in Korean Patients with Human Immunodeficiency Virus 1 Infection: A Post-Marketing Observational Study

A Randomized Phase I Pharmacokinetic Study Comparing Biosimilar Candidate SB3 and Trastuzumab in Healthy Male Subjects

Quality of Life in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: Changes in the MOSAIK Cohort Over 1 Year

Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: results from the MOSAIK cohort in Korea

Clinical outcomes in adult patients with plaque psoriasis treated with ustekinumab under real‐world practice in Korea: A prospective, observational, multi‐center, postmarketing surveillance study

Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea

Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea

Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasis

Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea

Tu1825 EFFECTIVENESS OF EARLY THIOPURINE USE IN KOREAN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE MULTICENTER COHORT (MOSAIK) STUDY

Effectiveness of Early Thiopurine Use in Korean Patients With Moderate-to-Severe Ulcerative Colitis: A Prospective Multicenter Cohort (MOSAIK) Study

Mo1855 ONE-YEAR SAFETY AND EFFECTIVENESS OF USTEKINUMAB IN PATEITNS WITH CROHN'S DISEASE: THE K-STAR STUDY

One-year Safety and Effectiveness of Ustekinumab in Patients With Crohn's Disease: The K-STAR Study

Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea

EP1027: DISCORDANCE BETWEEN PATIENT-REPORTED SYMPTOMS AND ENDOSCOPIC MUCOSAL INFLAMMATION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

Early course of newly diagnosed moderate‐to‐severe ulcerative colitis in Korea: Results from a hospital‐based inception cohort study (MOSAIK)

Suchergebnisse filtern